(Q77178277)
Statements
Complications associated with combined use of abciximab and an intracoronary thrombolytic agent (urokinase or tissue-type plasminogen activator) (English)
R A Yaryura
M Zaqqa
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference